Latest News about SNY
Recent news which mentions SNY
   Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics
   
  
  
  May 10, 2023
  From Benzinga
 
   7 Blue-Chip Stocks to Buy in May 2023
   
  
  
  May 04, 2023
  From InvestorPlace
 From Benzinga
 From InvestorPlace
 From Benzinga
 
   European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
   
  
  
  May 01, 2023
  From Benzinga
 
   Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront
   
  May 01, 2023
  Tickers 
   SNY
  
  
  From Benzinga
 From Benzinga
 
   Earnings Scheduled For April 27, 2023
   
  
  
  April 27, 2023
  From Benzinga
 
   US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
   
  
  
  April 27, 2023
  From Benzinga
 
   Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
   
  
  
  April 24, 2023
  From Benzinga
 
   United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
   
  
  
  April 21, 2023
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information
   
  
  
  April 11, 2023
  From Benzinga
 
   Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
   
  
  
  April 11, 2023
  From Benzinga
 
   Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
   
  
  
  April 11, 2023
  From Benzinga
 
   2 Top Healthcare Stocks Defying the Bear Market
   
  
  
  April 07, 2023
  From Motley Fool
 
   Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market
   
  
  
  April 06, 2023
  From Motley Fool
 From Motley Fool
 From Motley Fool
 
   Is Sanofi Stock a Buy Now?
   
  
  
  March 25, 2023
  From Motley Fool
 
   Regeneron Pharmaceuticals Analysts React To Drug Trial Results: Why Whales Are Diving In
   
  
  
  March 24, 2023
  From Benzinga
 
   Regeneron Pharmaceuticals Options Traders Betting On Stock Falling This Much By April Expiration
   
  
  
  March 24, 2023
  From Benzinga
 
   Why Shares of Regeneron Are Rising Thursday
   
  
  
  March 23, 2023
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
